The fact
The clinical trial shows good tolerance and preliminary signs of efficacy.
This innovation could target people unable to exercise for medical reasons.
Click the link to read an article on the topic:
The clinical trial shows good tolerance and preliminary signs of efficacy.
This innovation could target people unable to exercise for medical reasons.